We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLND icon
2826
Blend Labs
BLND
$360M
$44K ﹤0.01%
7,630
+7,622
+95,275% +$59K
EWG icon
2827
iShares MSCI Germany ETF
EWG
$1.69B
$44K ﹤0.01%
1,545
+836
+118% +$25.5K
EXPO icon
2828
Exponent
EXPO
$3.21B
$44K ﹤0.01%
408
-1,181
-74% -$114K
IVVD icon
2829
Invivyd
IVVD
$201M
$44K ﹤0.01%
9,613
+4,469
+87% +$27.3K
JELD icon
2830
JELD-WEN Holding
JELD
$167M
$44K ﹤0.01%
2,157
-601
-22% -$14.2K
KW
2831
DELISTED
Kennedy-Wilson Holdings
KW
$44K ﹤0.01%
1,822
+407
+29% +$9.37K
LAKE icon
2832
Lakeland Industries
LAKE
$118M
$44K ﹤0.01%
2,297
+1,803
+365% +$36K
LYEL icon
2833
Lyell Immunopharma
LYEL
$329M
$44K ﹤0.01%
433
-9
-2% -$1.09K
LZB icon
2834
La-Z-Boy
LZB
$1.66B
$44K ﹤0.01%
1,668
-1,794
-52% -$57.4K
EZRA
2835
Reliance Global Group
EZRA
$1.87M
$44K ﹤0.01%
+1
New +$61.5K
SLNH icon
2836
Soluna Holdings
SLNH
$199M
$44K ﹤0.01%
+159
New +$39.6K
SNY icon
2837
Sanofi
SNY
$104B
$44K ﹤0.01%
854
-1,835
-68% -$94.8K
UTI icon
2838
Universal Technical Institute
UTI
$1.39B
$44K ﹤0.01%
4,942
+1,822
+58% +$14.9K
VCV icon
2839
Invesco California Value Municipal Income Trust
VCV
$529M
$44K ﹤0.01%
3,964
+3,729
+1,587% +$44.7K
VTGN icon
2840
VistaGen Therapeutics
VTGN
$11.8M
$44K ﹤0.01%
1,185
+470
+66% +$20.5K
XENE icon
2841
Xenon Pharmaceuticals
XENE
$6.09B
$44K ﹤0.01%
1,462
+816
+126% +$24.4K
TFFP
2842
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$44K ﹤0.01%
281
+229
+440% +$37K
BIOR
2843
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$44K ﹤0.01%
150
+94
+168% +$35.7K
AVAV icon
2844
AeroVironment
AVAV
$9.79B
$43K ﹤0.01%
449
-3,141
-87% -$217K
BTZ icon
2845
BlackRock Credit Allocation Income Trust
BTZ
$955M
$43K ﹤0.01%
+3,436
New +$45.4K
BUD icon
2846
AB InBev
BUD
$156B
$43K ﹤0.01%
717
-116
-14% -$7.15K
BWMN icon
2847
Bowman Consulting
BWMN
$732M
$43K ﹤0.01%
+2,627
New +$46.6K
CIB icon
2848
Grupo Cibest SA
CIB
$23.3B
$43K ﹤0.01%
1,000
+952
+1,983% +$34.4K
CLSK icon
2849
CleanSpark
CLSK
$2.98B
$43K ﹤0.01%
3,551
+460
+15% +$4.25K
CRBU icon
2850
Caribou Biosciences
CRBU
$154M
$43K ﹤0.01%
4,681
+2,021
+76% +$21.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.